Nosocomial outbreak of extended-spectrum β-lactamase-producing Enterobacter cloacae among cardiothoracic surgical patients: causes and consequences.


Journal

The Journal of hospital infection
ISSN: 1532-2939
Titre abrégé: J Hosp Infect
Pays: England
ID NLM: 8007166

Informations de publication

Date de publication:
May 2019
Historique:
received: 14 10 2018
accepted: 02 01 2019
pubmed: 11 1 2019
medline: 14 6 2019
entrez: 11 1 2019
Statut: ppublish

Résumé

Enterobacteriaceae are recognized as leading pathogens of healthcare-associated infections. To report the investigation of a nosocomial outbreak of extended-spectrum β-lactamase-producing Enterobacter cloacae affecting cardiothoracic surgery patients in a Belgian academic hospital. Cases were defined based on epidemiological and microbiological investigations, including molecular typing using repetitive element-based polymerase chain reaction and multi-locus sequence typing. Case-control studies followed by field evaluations allowed the identification of a possible reservoir, and the retrospective assessment of human and financial consequences. Over a three-month period, 42 patients were infected or colonized by CTX-M-15-producing E. cloacae strains that belonged to the same clonal lineage. Acquisition mainly occurred in the intensive care unit (N = 23) and in the cardiothoracic surgery ward (N = 16). All but one patient had, prior to acquisition, undergone a cardiothoracic surgical procedure, monitored by the same transoesophageal echocardiography (TOE) probe in the operating room. Despite negative microbiological culture results, the exclusion of the suspected probe resulted in rapid termination of the outbreak. Overall, the outbreak was associated with a high mortality rate among infected patients (40%) as well as significant costs (€266,550). The outbreak was indirectly shown to be associated with the contamination of a manually disinfected TOE probe used per-operatively during cardiothoracic surgery procedures, because withdrawal of the putative device led to rapid termination of the outbreak.

Sections du résumé

BACKGROUND BACKGROUND
Enterobacteriaceae are recognized as leading pathogens of healthcare-associated infections.
AIM OBJECTIVE
To report the investigation of a nosocomial outbreak of extended-spectrum β-lactamase-producing Enterobacter cloacae affecting cardiothoracic surgery patients in a Belgian academic hospital.
METHODS METHODS
Cases were defined based on epidemiological and microbiological investigations, including molecular typing using repetitive element-based polymerase chain reaction and multi-locus sequence typing. Case-control studies followed by field evaluations allowed the identification of a possible reservoir, and the retrospective assessment of human and financial consequences.
FINDINGS RESULTS
Over a three-month period, 42 patients were infected or colonized by CTX-M-15-producing E. cloacae strains that belonged to the same clonal lineage. Acquisition mainly occurred in the intensive care unit (N = 23) and in the cardiothoracic surgery ward (N = 16). All but one patient had, prior to acquisition, undergone a cardiothoracic surgical procedure, monitored by the same transoesophageal echocardiography (TOE) probe in the operating room. Despite negative microbiological culture results, the exclusion of the suspected probe resulted in rapid termination of the outbreak. Overall, the outbreak was associated with a high mortality rate among infected patients (40%) as well as significant costs (€266,550).
CONCLUSION CONCLUSIONS
The outbreak was indirectly shown to be associated with the contamination of a manually disinfected TOE probe used per-operatively during cardiothoracic surgery procedures, because withdrawal of the putative device led to rapid termination of the outbreak.

Identifiants

pubmed: 30630000
pii: S0195-6701(19)30003-9
doi: 10.1016/j.jhin.2019.01.001
pii:
doi:

Substances chimiques

beta-Lactamases EC 3.5.2.6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

54-60

Informations de copyright

Copyright © 2019. Published by Elsevier Ltd.

Auteurs

A Noël (A)

Infection Control Unit, CHU UCL Namur, Yvoir, Belgium. Electronic address: audrey.noel@uclouvain.be.

C Vastrade (C)

Infection Control Unit, CHU UCL Namur, Yvoir, Belgium.

S Dupont (S)

Infection Control Unit, CHU UCL Namur, Yvoir, Belgium.

M de Barsy (M)

National Reference Centre for Monitoring Antimicrobial Resistance in Gram-Negative Bacteria, CHU UCL Namur, Yvoir, Belgium.

T D Huang (TD)

National Reference Centre for Monitoring Antimicrobial Resistance in Gram-Negative Bacteria, CHU UCL Namur, Yvoir, Belgium.

T Van Maerken (T)

Infection Control Unit, Ghent University Hospital, Ghent, Belgium.

I Leroux-Roels (I)

Infection Control Unit, Ghent University Hospital, Ghent, Belgium.

B Delaere (B)

Infectious Diseases Unit, Internal Medicine Department, CHU UCL Namur, Yvoir, Belgium.

L Melly (L)

Cardiovascular, Thoracic Surgery and Lung Transplantation Department, CHU UCL Namur, Yvoir, Belgium.

B Rondelet (B)

Cardiovascular, Thoracic Surgery and Lung Transplantation Department, CHU UCL Namur, Yvoir, Belgium.

C Dransart (C)

Anesthesiology Department, CHU UCL Namur, Yvoir, Belgium.

A S Dincq (AS)

Anesthesiology Department, CHU UCL Namur, Yvoir, Belgium.

I Michaux (I)

Intensive Care Unit Department, CHU UCL Namur, Yvoir, Belgium.

P Bogaerts (P)

National Reference Centre for Monitoring Antimicrobial Resistance in Gram-Negative Bacteria, CHU UCL Namur, Yvoir, Belgium.

Y Glupczynski (Y)

Infection Control Unit, CHU UCL Namur, Yvoir, Belgium; National Reference Centre for Monitoring Antimicrobial Resistance in Gram-Negative Bacteria, CHU UCL Namur, Yvoir, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH